Wedbush analyst David Nierengarten lowered the price target on Disc Medicine (NASDAQ: IRON) to $43.00 (from $84.00) while maintaining a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE